Investigating How Childhood Tumours and Congenital Disease Develop

Enrolling by invitationOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

February 2, 2017

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Childhood TumorCongenital Disorders
Interventions
OTHER

sample collection

Surplus material from surgery. New or stored blood or saliva. Semen (from adult males).

OTHER

Seeking consent and assent

Consent or assent from all participants to be included in the study. Consent from parent / guardian for inclusion of children in study (as primary participant or relative/sibling, as applicable).

Trial Locations (1)

Unknown

Wellcome Sanger Institute, Cambridge

All Listed Sponsors
lead

The Wellcome Sanger Institute

OTHER